ArticleESMO open2023
Access to novel cancer medicines in four countries in Central and Eastern Europe in relation to clinical benefit.
T Hofmarcher et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it